跳至主要内容
临床试验/NCT06549387
NCT06549387尚未招募不适用

Topo-Pachymetric Customized Accelerated Epithelium-On Versus Standard Accelerated Epithelium-Off Corneal Collagen Cross Linking in the Management of Keratoconus

Kasr El Aini Hospital1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2024年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
55
试验地点
1
主要终点
Change in the endothelial cell count.

研究概览

简要总结

The objective of this study is to compare the clinical effectiveness and safety of Topo-Pachymetric Customized Accelerated Epithelium-On (aCFXL) to Standard Accelerated Epithelium-Off (aCXL) Corneal Collagen Cross-Linking in the management of keratoconus. The study aims to evaluate visual and structural outcomes, to provide valuable insights into optimizing treatment strategies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age: 18 years or older
  • •Corrected distance visual acuity (CDVA) of ≥ 0.3 Snellen.
  • •Central corneal thickness (de-epithelialized) of ≥ 400 micron.
  • •Corneal endothelial count of ≥ 2000.

排除标准

  • •Previous eye surgery
  • •The presence of lesions other than keratoconus, central or paracentral scaring
  • •History of Cross linking
  • •History of viral keratitis
  • •Connective tissue diseases
  • •Pregnancy or lactation during the study.
  • •The presence of nystagmus

研究组 & 干预措施

The standard accelerated CXL (aCXL) protoco

Active Comparator

干预措施: Corneal cross linking (Procedure)

Progressive Fluence Epi-on accelerated crosslinking M nomogram

Active Comparator

干预措施: Corneal cross linking (Procedure)

The topo-pachimetric customized accelerated epithelium-On (aCFXL group)

Active Comparator

干预措施: Corneal cross linking (Procedure)

结局指标

主要结局

Change in the endothelial cell count.

时间窗: 6 months

the stability or decrease in the endothelial cell count.

Amount of corneal flattening

时间窗: 6 months

Kmax flattening

次要结局

  • Best corrected visual acuity(6 months)

研究者

发起方
Kasr El Aini Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Paula Sameh Youssef

M.Sc.

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验